The Patent Finder

Y-Mabs Therapeutics, Inc.

7 applications · Updated Nov 20, 2026

Patents held now

No granted US patent is recorded under this name. The published applications below are what the record holds.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 1 abandoned · 1 no status recorded

Showing 1 to 7 of 7, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/421,157Use of ANTI-B7H3 Antibodies for Treating Cancer in the Central Nervous SystemJan 24, 2024Pending
18/717,536scFv and Antibodies with Reduced MultimerisationDec 14, 2022Pending
18/717,256Formulations Comprising a SADA ComplexDec 14, 2022Pending
18/008,581CD38 antibodies for the treatment of human diseasesJun 14, 2021Pending
17/924,161Anti-B7H3 Antibodies for the Treatment of CancerJun 1, 2021Pending
17/917,377Apr 21, 2021No status recorded
16/613,028Use of ANTI-B7H3 Antibodies for Treating Cancer in the Central Nervous SystemMay 14, 2018Abandoned

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited